Frontlight ResearchEarly access
Trial site
OnkoNet Marburg GmbH
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer1 trial
- Immune thrombocytopenia (ITP)1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 22 trials
- Phase 31 trial
- Phase 41 trial
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- AGO Research GmbH1 trial
- Dominik Paul Modest1 trial
- Institut Für Frauengesundheit GmbH1 trial
- Takeda1 trial
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026